N-6:n-3 PUFA ratio is involved in regulating lipid metabolism and inflammation in pigs

British Journal of Nutrition

Volumn 111, Issue 3, 2014, Pages 445-451

  Duan, Yehui ^a,b   Li, Fengna ^a   Li, Lili ^a   Fan, Juexin ^c   Sun, Xiaoming ^a,d   Yin, Yulong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c HUNAN AGRICULTURAL UNIVERSITY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Inflammation; Lipid metabolism; n 6:n 3 ratios; Pigs; PUFA

Indexed keywords

ADIPOKINES; ADIPOSITY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHINA; CROSSES, GENETIC; CYTOKINES; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MALE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; RANDOM ALLOCATION; SUBCUTANEOUS FAT, ABDOMINAL; SUS SCROFA; WEIGHT GAIN;

EID: 84893690580     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513002584     Document Type: Article

References (36)

1. Lim GP, Calon F, Morihara T, et al. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25, 3032-3040.
2. Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502-507.
3. Simopoulos AP (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56, 365-379.
4. Kobayashi N, Barnard RJ, Henning SM, et al. (2006) Effect of altering dietary v-6/v-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 12, 4662-4670.
5. Hibbeln JR, Nieminen LR, Blasbalg TL, et al. (2006) Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 83, 1483S-1493S.
6. Gamoh S, Hashimoto M, Hossain S, et al. (2001) Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 28, 266-270.
7. Ikemoto A, Ohishi M, Sato Y, et al. (2001) Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42, 1655-1663.
8. Catalan J, Moriguchi T, Slotnick B, et al. (2002) Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci 116, 1022-1031.
9. Raheja B, Sadikot SM, Phatak RB, et al. (1993) Significance of the n-6/n-3 ratio for insulin action in diabetes. Ann N Y Acad Sci 683, 258-271.
10. Weaver KL, Ivester P, Seeds M, et al. (2009) Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem 284, 15400-15407.
11. Dutta-Roy AK (2000) Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 71, Suppl., 315S-322S.
12. Newman RE, Bryden WL, Fleck E, et al. (2002) Dietary n-3 and n-6 fatty acids alter avian metabolism: metabolism and abdominal fat deposition. Br J Nutr 88, 11-18.
13. Ferrini G, Baucells MD, Esteve-Garcia E, et al. (2008) Dietary polyunsaturated fat reduces skin fat as well as abdominal fat in broiler chickens. Poult Sci 87, 528-535.
14. Qi KK (2009) Effect of dietary v6/v3 on fatty acid composition and meat quality in chicken. PhD Thesis, Chinese Academy of Agricultural Sciences, Animal Nutrition Department, Beijing.
15. Drevon CA (2005) Fatty acids and expression of adipokines. Biochim Biophys Acta 1740, 287-292.
16. Stefan N, Wahl HG, Fritsche A, et al. (2001) Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res 33, 432-438.
17. Neschen S, Morino K, Rossbacher JC, et al. (2006) Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-g-dependent mechanism in mice. Diabetes 55, 924-928.
18. Lago F, Dieguez C, Gómez-Reino J, et al. (2007) The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18, 313-325.
19. Xu F, Fan CN, Zhu HY, et al. (2009) Effects of dietary ratio changes of n-6/n-3 polyunsaturated fatty acids on expression of plasma leptin in mice. J Appl Clin Pediatr 24, 500-502.
20. Tai CC & Ding ST (2010) n-3 Polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 21, 357-363.
21. Lafontan M & Langin D (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48, 275-297.
22. Rallidis L, Paschos G, Liakos GK, et al. (2003) Dietary alphalinolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167, 237-242.
23. Caughey GE, Mantzioris E, Gibson RA, et al. (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116-122.
24. Calder PC (2001) n-3 Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36, 1007-1024.
25. Calder PC (2002) Dietary modification of inflammation with lipids. Proc Nutr Soc 61, 345-358.
26. Lindmo K & Stenmark H (2005) Regulation of membrane traffic by phosphoinositide 3-kinases. J Cell Sci 119, 605-614.
27. Madsen L, Petersen RK & Kristiansen K (2005) Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim Biophys Acta 1740, 266-286.
28. Moraes LA, Piqueras L & Bishop-Bailey D (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110, 371-385.
29. Feige JN, Gelman L, Michalik L, et al. (2006) From molecular action to physiological outputs: peroxisome proliferatoractivated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 45, 120-159.
30. Michalik L, Auwerx J, Berger JP, et al. (2006) International union of pharmacology. LXI. Peroxisome proliferatoractivated receptors. Pharmacol Rev 58, 726-741.
31. Edwards IJ & O'Flaherty JT (2008) Omega-3 fatty acids and PPARg in cancer. PPAR Res 2008, 358052.
32. Camp HS, Tafuri SR & Leff T (1999) C-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptorg1 and negatively regulates its transcriptional activity. Endocrinology 140, 392-397.
33. Dorman CM & Johnson SE (1999) Activated Raf inhibits avian myogenesis though a MAPK dependent mechanism. Oncogene 18, 5167-5176.
34. Lee MY, Jeong WJ, Oh JW, et al. (2009) NM23H2 inhibits EGF-and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway. Cancer Lett 275, 221-226.
35. Jiang C, Ting AT & Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
36. Escher P & Wahli W (2000) Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448, 121-138.